Halozyme Therapeutics
HALO
New Fortress Energy
NFE
DexCom
DXCM
4
YETI Holdings
YETI
5
Teradata Corp
TDC
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 17.73%1.26B | -4.84%5.25B | -6.78%1.39B | 8.63%1.69B | -9.41%1.11B | -14.79%1.07B | -0.22%5.51B | 17.15%1.49B | -10.03%1.55B | -0.73%1.22B |
Net income from continuing operations | -26.59%646M | -5.40%3.47B | -16.89%733M | 7.97%894M | -0.82%963M | -10.84%880M | -10.84%3.67B | -8.70%882M | -25.47%828M | -17.57%971M |
Operating gains losses | ---- | 67.65%-11M | 62.50%-3M | 116.67%1M | ---- | ---- | 85.71%-34M | 85.45%-8M | 77.78%-6M | 90.70%-12M |
Depreciation and amortization | 3.66%425M | 3.17%1.66B | 4.20%422M | 3.23%416M | 0.99%410M | 4.33%410M | 6.99%1.61B | 2.53%405M | 6.61%403M | 10.03%406M |
Deferred tax | 85.71%13M | -90.48%12M | -124.14%-7M | -81.48%5M | -80.00%7M | -80.00%7M | 26.00%126M | 216.00%29M | 42.11%27M | -49.28%35M |
Other non cash items | 76.47%-4M | -814.29%-64M | 60.81%-29M | -151.02%-25M | -85.71%7M | 45.16%-17M | 56.25%-7M | -305.56%-74M | 228.95%49M | 372.22%49M |
Change In working capital | 181.78%175M | -51.95%74M | -35.69%164M | 57.37%395M | -19.38%-271M | -71.20%-214M | 140.63%154M | 654.35%255M | -10.99%251M | 4.62%-227M |
-Change in receivables | -280.00%-9M | 260.78%82M | 435.71%75M | 135.62%26M | -133.80%-24M | 107.94%5M | 49.50%-51M | -66.67%14M | -232.73%-73M | 205.97%71M |
-Change in payables and accrued expense | 471.83%264M | -104.68%-24M | -65.46%67M | 15.69%354M | -15.79%-374M | -121.13%-71M | 407.92%513M | 322.99%194M | 264.29%306M | -59.11%-323M |
-Change in other current assets | -17.24%-34M | 140.18%45M | 164.29%18M | -90.91%2M | 258.82%54M | 59.72%-29M | -366.67%-112M | -450.00%-28M | -43.59%22M | -9.68%-34M |
-Change in other current liabilities | 61.34%-46M | 85.20%-29M | -94.67%4M | 425.00%13M | 23.73%73M | 63.50%-119M | -322.73%-196M | 933.33%75M | -103.85%-4M | -6.35%59M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 17.73%1.26B | -4.84%5.25B | -6.78%1.39B | 8.63%1.69B | -9.41%1.11B | -14.79%1.07B | -0.22%5.51B | 17.15%1.49B | -10.03%1.55B | -0.73%1.22B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -33.13%-647M | -16.97%-2.61B | -22.47%-883M | -20.14%-674M | -20.86%-562M | -1.25%-486M | -7.95%-2.23B | -72.08%-721M | 10.24%-561M | 28.57%-465M |
Net PPE purchase and sale | -37.55%-696M | -13.55%-2.46B | -23.98%-822M | -10.16%-618M | -1.37%-517M | -16.32%-506M | -19.24%-2.17B | -53.12%-663M | 7.12%-561M | -11.11%-510M |
Net business purchase and sale | --0 | -125.81%-70M | ---2M | ---18M | 17.24%-24M | -1,200.00%-26M | 86.34%-31M | --0 | --0 | 85.43%-29M |
Net investment purchase and sale | -17.28%67M | -48.98%25M | -5,500.00%-56M | --0 | --0 | 268.75%81M | 198.00%49M | 97.50%-1M | ---1M | 1,000.00%99M |
Net other investing changes | 48.57%-18M | -27.63%-97M | 94.74%-3M | -3,900.00%-38M | 16.00%-21M | -800.00%-35M | -330.30%-76M | -198.28%-57M | 116.67%1M | -1,150.00%-25M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -33.13%-647M | -16.97%-2.61B | -22.47%-883M | -20.14%-674M | -20.86%-562M | -1.25%-486M | -7.95%-2.23B | -72.08%-721M | 10.24%-561M | 28.57%-465M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 10.67%-402M | 20.82%-3.06B | -56.90%-1.22B | -3.24%-606M | 25.96%-790M | 68.71%-450M | -2.60%-3.87B | 36.99%-775M | -220.53%-587M | 40.46%-1.07B |
Net issuance payments of debt | 30,000.00%598M | -101.79%-8M | 33.33%-2M | -100.34%-2M | 50.00%-2M | 98.59%-2M | -75.36%447M | 62.50%-3M | -68.88%596M | 95.40%-4M |
Net common stock issuance | -204.05%-751M | 35.76%-2.24B | -76.42%-1.03B | 58.60%-402M | 34.76%-563M | 76.85%-247M | 26.40%-3.48B | 43.10%-581M | 18.74%-971M | 42.43%-863M |
Cash dividends paid | -4.26%-245M | -5.44%-930M | -6.48%-230M | -6.42%-232M | -4.95%-233M | -3.98%-235M | -3.52%-882M | -4.35%-216M | -2.83%-218M | -3.26%-222M |
Net other financing activities | -111.76%-4M | 126.00%113M | 64.00%41M | 400.00%30M | -63.64%8M | 1,233.33%34M | --50M | --25M | 128.57%6M | 144.44%22M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 10.67%-402M | 20.82%-3.06B | -56.90%-1.22B | -3.24%-606M | 25.96%-790M | 68.71%-450M | -2.60%-3.87B | 36.99%-775M | -220.53%-587M | 40.46%-1.07B |
Net cash flow | ||||||||||
Beginning cash position | -31.04%933M | -30.01%1.35B | 20.88%1.64B | 29.50%1.24B | 14.87%1.48B | -30.90%1.35B | -13.67%1.93B | -41.15%1.36B | 32.04%956M | -33.32%1.29B |
Current changes in cash | 58.46%206M | 27.59%-420M | -10,057.14%-711M | 0.50%406M | 20.97%-245M | 119.49%130M | -89.54%-580M | 98.15%-7M | -74.54%404M | 74.42%-310M |
End cash Position | -23.20%1.14B | -31.04%933M | -31.04%933M | 20.88%1.64B | 29.50%1.24B | 14.87%1.48B | -30.01%1.35B | -30.01%1.35B | -41.15%1.36B | 32.04%956M |
Free cash flow | -2.37%536M | -16.55%2.72B | -31.51%550M | 8.49%1.06B | -16.47%558M | -32.05%549M | -4.57%3.26B | 34.96%803M | -11.01%978M | -11.05%668M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |